These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 9566927)

  • 1. Gene amplification in a p53-deficient cell line requires cell cycle progression under conditions that generate DNA breakage.
    Paulson TG; Almasan A; Brody LL; Wahl GM
    Mol Cell Biol; 1998 May; 18(5):3089-100. PubMed ID: 9566927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inefficient growth arrest in response to dNTP starvation stimulates gene amplification through bridge-breakage-fusion cycles.
    Poupon MF; Smith KA; Chernova OB; Gilbert C; Stark GR
    Mol Biol Cell; 1996 Mar; 7(3):345-54. PubMed ID: 8868464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYC abrogates p53-mediated cell cycle arrest in N-(phosphonacetyl)-L-aspartate-treated cells, permitting CAD gene amplification.
    Chernova OB; Chernov MV; Ishizaka Y; Agarwal ML; Stark GR
    Mol Cell Biol; 1998 Jan; 18(1):536-45. PubMed ID: 9418900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53-dependent growth arrest of REF52 cells containing newly amplified DNA.
    Ishizaka Y; Chernov MV; Burns CM; Stark GR
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3224-8. PubMed ID: 7724543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased methotrexate resistance and dhfr gene amplification as a consequence of induced Ha-ras expression in NIH 3T3 cells.
    Wani MA; Xu X; Stambrook PJ
    Cancer Res; 1994 May; 54(9):2504-8. PubMed ID: 8162600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribonucleotide reductase R2 gene expression and changes in drug sensitivity and genome stability.
    Huang A; Fan H; Taylor WR; Wright JA
    Cancer Res; 1997 Nov; 57(21):4876-81. PubMed ID: 9354452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug resistance in KHT fibrosarcoma cell lines with different metastatic ability.
    Cillo C; Ling V; Hill RP
    Int J Cancer; 1989 Jan; 43(1):107-11. PubMed ID: 2910823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic resistance to methotrexate and N-phosphonacetyl L-aspartate is induced by treatment with 12-O-tetradecanoylphorbol-13-acetate (TPA).
    Kinsella AR; Fox M
    Int J Cancer; 1988 Jul; 42(1):87-93. PubMed ID: 3391708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor mediated alterations in drug resistance, and evidence of gene amplification.
    Huang A; Wright JA
    Oncogene; 1994 Feb; 9(2):491-9. PubMed ID: 7904743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of single-step mutants of Syrian hamster cell lines resistant to N-(phosphonacetyl)-L-aspartate.
    Zieg J; Clayton CE; Ardeshir F; Giulotto E; Swyryd EA; Stark GR
    Mol Cell Biol; 1983 Nov; 3(11):2089-98. PubMed ID: 6656764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The presence of amplified regions affects the stability of chromosomes in drug-resistant Chinese hamster cells.
    Miele M; Bonatti S; Menichini P; Ottaggio L; Abbondandolo A
    Mutat Res; 1989 May; 219(3):171-8. PubMed ID: 2567961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hamster cells with increased rates of DNA amplification, a new phenotype.
    Giulotto E; Knights C; Stark GR
    Cell; 1987 Mar; 48(5):837-45. PubMed ID: 3815526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein alterations associated with gene amplification in cultured human and rodent cells.
    Conner EA; Wirth PJ
    Electrophoresis; 1996 Jul; 17(7):1257-64. PubMed ID: 8855414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of gene amplification as a gain-of-function phenotype of mutant p53 proteins.
    El-Hizawi S; Lagowski JP; Kulesz-Martin M; Albor A
    Cancer Res; 2002 Jun; 62(11):3264-70. PubMed ID: 12036943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene amplification causes overproduction of the first three enzymes of UMP synthesis in N-(phosphonacetyl)-L-aspartate-resistant hamster cells.
    Wahl GM; Padgett RA; Stark GR
    J Biol Chem; 1979 Sep; 254(17):8679-89. PubMed ID: 381311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Geminin functions downstream of p53 in K-ras-induced gene amplification of dihydrofolate reductase.
    Shen L; Nishioka T; Guo J; Chen C
    Cancer Res; 2012 Dec; 72(23):6153-62. PubMed ID: 23026135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of amplified DNA in different Syrian hamster cell lines resistant to N-(phosphonacetyl)-L-aspartate.
    Ardeshir F; Giulotto E; Zieg J; Brison O; Liao WS; Stark GR
    Mol Cell Biol; 1983 Nov; 3(11):2076-88. PubMed ID: 6656763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The propensity for gene amplification: a comparison of protocols, cell lines, and selection agents.
    Sharma RC; Schimke RT
    Mutat Res; 1994 Jan; 304(2):243-60. PubMed ID: 7506368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage inhibitory cytokine 1 mediates a p53-dependent protective arrest in S phase in response to starvation for DNA precursors.
    Agarwal MK; Hastak K; Jackson MW; Breit SN; Stark GR; Agarwal ML
    Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16278-83. PubMed ID: 17050687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosome rearrangements associated with CAD gene amplification. Experiments with cell hybrids.
    Viaggi S; Nüsse M; Ottaggio L; Bonatti S
    Mutat Res; 1992 Jan; 265(1):9-21. PubMed ID: 1370246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.